4160
P.-Y. Chen et al. / Tetrahedron 67 (2011) 4155e4160
1691 (C]O); 1H NMR (CDCl3, 400 MHz)
d
2.96 (dd, J¼16.8, 3.6 Hz,
(70%), 4e (69%), 4f (78%), 4g (76%), 4h (74%), and 4i (72%) were
obtained, respectively.
1H, Ha-3), 3.04 (dd, J¼16.8, 12.4Hz, 1H, Hb-3), 5.62 (dd, J¼12.4,
3.6 Hz, 1H, H-2), 7.11(m, 2H, ArH), 7.56 (td, J¼8.4, 1.6 Hz, 1H, ArH),
7.69 (dd, J¼8.4, 2.0 Hz, 2H, ArH), 7.95 (dd, J¼8.0, 2.0 Hz, 1H, ArH),
Acknowledgements
8.31 (dd, J¼8.8, 2.0 Hz, 2H, ArH); 13C NMR (CDCl3, 100 MHz)
d 44.6,
78.3, 118.0, 120.9, 122.2, 124.1, 126.8, 127.2, 136.5, 136.3, 148.8, 160.9,
190.7; EIMS (70 eV) m/z (rel intensity, %) 269 (Mþ, 33), 268 (49), 252
(18), 147 (91), 121 (20), 120 (53), 93 (100), 64 (13). Anal. Calcd for
C15H11NO4: C, 66.91; H, 4.12; N, 5.20. Found: C, 66.82; H, 4.13; N,
5.10.
The research grants from the National Science Council (NSC-99-
2113-M-037-007) and Kaohsiung Medical University (N-843) of
Taiwan are grateful.
References and notes
4.1.2.7. 30-Nitroflavanone (4g). Compound 4g (0.36 g, 84%) was
obtained as colorless crystals, mp¼145e146 ꢀC (lit.22 mp 142 ꢀC);
Rf¼0.31(ethyl acetate/n-hexane¼1:4); IR (KBr) cmꢁ1:1693 (C]O);
1. Vauzour, D.; Vafeiadou, K.; Rice-Evans, C.; Williams, R. J.; Spencer, J. P. E. J.
Neurochem. 2007, 103, 1355e1367.
2. Agarwal, C.; Tyagi, A.; Kaur, M.; Agarwal, R. Carcinogenesis 2007, 28, 1463e1470.
3. Cabrera, M.; Simoens, M.; Falchi, G.; Lavaggi, M. L.; Piro, O. E.; Castellano, E. E.;
Vidal, A.; Azqueta, A.; Monge, A.; Lopez de Cerain, A.; Sagrera, G.; Seoane, G.;
Cerecetto, H.; Gonzalez, M. Bioorg. Med. Chem. 2007, 15, 3356e3367.
4. Hsiao, Y. C.; Kuo, W. H.; Chen, P. N.; Chang, H. R.; Lin, T. H.; Yang, W. E.; Hsieh, Y.
S.; Chu, S. C. Chem.-Biol. Interact. 2007, 167, 193e206.
1H NMR (CDCl3, 400 MHz)
d
2.96 (dd, J¼16.8, 3.2 Hz, 1H, Ha-3), 3.08
(dd, J¼16.8, 12.8 Hz, 1H, Hb-3), 5.61 (dd, J¼12.8, 3.2 Hz, 1H, H-2),
7.11 (m, 2H, ArH), 7.56 (td, J¼8.4, 1.6 Hz, 1H, ArH), 7.64 (t, J¼8.0 Hz,
1H, ArH), 7.81 (m,1H, ArH), 7.95 (dd, J¼8.0,1.6 Hz,1H, ArH), 8.26 (m,
1H, ArH), 8.42 (t, J¼2.0 Hz, 1H, ArH); 13C NMR (CDCl3, 100 MHz)
5. Ward, F. E.; Garling, D. L.; Buckler, R. T.; Lawler, D. M.; Cummings, D. P. J. Med.
Chem. 1981, 24, 1073e1077.
6. (a) Choi, Y. J.; Lee, M. K.; Lee, Y. J.; Jeong, Y. J.; Yoon Park, J. H.; Sung, L. S.; Kang,
Y. H. J. Med. Food 2004, 7, 408e416; (b) Varga, Z.; Seres, I.; Nagy, E.; Ujhelyi, L.;
Balla, G.; Balla, J.; Antus, S. Phytomedicine 2006, 13, 85e93; (c) Sun, J. M.; Yang,
J. S.; Zhang, H. Chem. Pharm. Bull. 2007, 55, 474e476; (d) Jung, H. A.; Jeong, D.
M.; Chung, H. Y.; Lim, H. A.; Kim, J. Y.; Yoon, N. Y.; Choi, J. S. Biol. Pharm. Bull.
2008, 31, 908e915.
7. (a) Njamen, D.; Mbafor, J. T.; Fomum, Z. T.; Kamanyi, A.; Mbanya, J. C.; Recio, M.
C.; Giner, R. M.; Manez, S.; Rios, J. L. Planta Med. 2004, 70, 104e107; (b) Ueda, H.;
Yamazaki, C.; Yamazaki, M. Biosci. Biotechnol. Biochem. 2004, 68, 119e125; (c)
Rotelli, A. E.; Guardia, Teresita; Juarez, Americo Osvaldo; De la Rocha, Nadir
Ernesto; Pelzer, L. E. Pharm. Res. 2003, 48, 601e606.
8. (a) Paredes, A.;Alzuru, M.; Mendez, J.; Rodriguez-Ortega, M. Biol. Pharm. Bull. 2003,
26, 108e109; (b) Kim, H. K.; Jeon, W. K.; Ko, B. S. Planta Med. 2001, 67, 548e549.
9. (a) Reddy, M. V. B.; Kishore, P. H.; Rao, C. V.; Gunasekar, D.; Caux, C.; Bodo, B. J.
Nat. Prod. 2003, 66, 295e297; (b) Siddikov, G. U.; Yuldashev, M. P.; Aripova, S. F.;
Vdovin, A. D.; Abdullaev, N. D.; Botirov, E. K. Chem. Nat. Compd. 2008, 44,
28e30; (c) Shakil, N. A.; Pankaj; Kumar, J.; Pandey, R. K.; Saxena, D. B. Phyto-
chemistry 2008, 69, 759e764; (d) Asai, T.; Hara, N.; Kobayashi, S.; Kohshima, S.;
Fujimoto, Y. Phytochemistry 2008, 69, 1234e1241.
d
44.6, 78.2, 118.1, 120.7, 121.2, 122.2, 123.6, 127.2, 129.9, 131.9, 136.5,
140.9, 148.6, 160.9, 190.8; EIMS (70 eV) m/z (rel intensity, %) 269
(Mþ, 35), 268 (39), 147 (100), 121 (33), 120 (66), 92 (99), 64 (19), 63
(23). Anal. Calcd for C15H11NO4: C, 66.91; H, 4.12; N, 5.20. Found: C,
66.51; H, 4.20; N, 5.13.
4.1.2.8. 6-Chloro-40-fluoroflavanone (4h). Compound 4h (0.36 g,
82%) was obtained as colorless crystals, mp¼145e146 ꢀC; Rf¼0.31
(ethyl acetate/n-hexane¼1:4); IR (KBr) cmꢁ1:1701 (C]O); 1H NMR
(CDCl3, 400 MHz)
d
2.89 (dd, J¼16.8, 2.8 Hz, 1H, Ha-3), 3.06 (dd,
J¼16.8, 13.2 Hz, 1H, Hb-3), 5.46 (dd, J¼13.2, 2.8 Hz, 1H, H-2), 7.01 (d,
J¼8.4 Hz, 1H, ArH), 7.14 (td, J¼8.8, 2.0 Hz, 2H, ArH), 7.45 (m, 3H,
ArH), 7.89 (d, J¼2.4 Hz, 1H, ArH); 13C NMR (CDCl3, 100 MHz)
d 44.3,
79.1, 115.9 (d, J¼21.2 Hz), 119.8, 121.6, 126.4, 127.3, 128.0 (d,
J¼8.4 Hz), 134.1, 136.1, 159.8, 162.9 (d, J¼246.3 Hz), 190.6; EIMS
(70 eV) m/z (rel intensity, %) 276 (Mþ, 91), 275 (77), 181 (36), 156
(37), 155 (27), 154 (100), 126 (40), 122 (40). Anal. Calcd for
C15H10ClFO2: C, 65.11; H, 3.64. Found: C, 65.05; H, 3.63.
10. Wang, X.; Cheng, S. Catal. Commun. 2006, 7, 689e695.
11. Drexler, M. T.; Amiridis, M. D. J. Catal. 2003, 214, 136e145.
12. Chandrasekhar, S.; Vijeender, K.; Reddy, K. V. Tetrahedron Lett. 2005, 46, 6991e6993.
13. Choudary, B. M.; Ranganath, K. V. S.; Yadav, J.; Kantam, M. L. Tetrahedron Lett.
2005, 46, 1369e1371.
14. Climent, M. J.; Corma, A.; Iborra, S.; Primo, J. J. Catal. 1995, 151, 60e66.
15. (a) Coetzee, J.; Mciteka, L.; Malan, E.; Ferreira, D. Phytochemistry 1999, 52,
737e743; (b) Dutta, C. P.; Roy Lala, P. K. Indian J. Chem. 1975, 13, 425e426.
16. (a) Adams, J. H. J. Org. Chem. 1967, 32, 3992e3998; (b) Brennan, C. M.; Hunt, I.;
Jarvis, T. C.; Johnson, C. D.; McDonnell, P. D. Can. J. Chem. 1990, 68, 1780e1785; (c)
Wurm, G.; Schnetzer, D. Arch. Pharm. (Weinheim) 1992, 325, 717e719; (d) Cha-
turvedi, R.; Patil, P. N.; Mulchandani, N. B. Indian J. Chem. 1992, 31B, 340e341.
17. (a) Climent, M. J.; Garcia, H.; Iborra, S.; Miranda, M. A.; Primo, J. Heterocycles
1989, 29, 115e121; (b) Reichel, L.; Weber, F. G. Pharmazie 1975, 30, 195e198; (c)
Patonay, T.; Litkei, G.; Zsuga, M.; Kiss, A. Org. Prep. Proced. Int. 1984, 16, 315e319.
18. Lee, J. I.; Jung, M. G.; Jung, H. J. Bull. Korean Chem. Soc. 2007, 28, 859e862.
19. Manivel; Rai, P.; Rai, N. P.; Jayashankara, V. P.; Arunachalam, P. N. Tetrahedron
Lett. 2007, 48, 2701e2705.
4.1.2.9. 6-Chloro-40-bromoflavanone (4i). Compound 4i (0.43 g,
80%) was obtained as colorless crystals, mp ¼151e152 ꢀC; Rf¼0.32
(ethyl acetate/n-hexane¼1:4); IR (KBr) cmꢁ1:1689 (C]O); 1H NMR
(CDCl3, 400 MHz)
d
2.89 (dd, J¼16.8, 3.2 Hz, 1H, Ha-3), 3.02 (dd,
J¼16.8, 12.8 Hz, 1H, Hb-3), 5.44 (dd, J¼12.8, 3.2 Hz, 1H, H-2), 7.01 (d,
J¼8.8 Hz, 1H, ArH), 7.35 (m, 2H, ArH), 7.46 (dd, J¼8.8, 2.0 Hz, 1H,
ArH), 7.57 (dd, J¼8.8, 2.0 Hz, 2H, ArH), 7.88 (d, J¼2.4 Hz, 1H, ArH);
13C NMR (CDCl3, 100 MHz)
d 44.2, 79.1, 119.8, 121.6, 122.9, 126.4,
127.4, 127.8, 132.1, 136.1, 137.3, 159.7, 190.4; EIMS (70 eV) m/z (rel
intensity, %) 337 (Mþ, 60), 336 (50), 335 (41), 184 (64), 182 (78), 181
(74), 154 (100), 103 (51). Anal. Calcd for C15H10BrClO2: C, 53.37; H,
2.99. Found: C, 53.47; H, 3.02.
20. The CIF file of crystal 3e has been deposited at the Cambridge Crystallographic
Centre (CCDC), UK, and received the CCDC no. 791334. The X-ray crystallo-
graphic study of 3e is summarized as follows. Crystal data: C15H13BrO3, M¼321.
ꢀ
ꢀ
16, monoclinic system, space group P21/n, a¼5.3393 (1) A, b¼8.5377 (17) A,
3
ꢀ
3
ꢀ
ꢀ
c¼29.789 (6) A, ¼92.52 (3) , V¼1357.0 (5) A , Z¼4, d¼1.572 g/cm . A crystal of
b
dimensions 0.70ꢂ0.42ꢂ0.30 mm was used for measurements on a RIGAKU
4.1.3. General procedure for the preparation of flavanones (4aei)
from o-hydroxyacetophenones (1a,b) and benzaldehydes (2aei) in
one pot. The mixture of 2-hydroxyacetophenones (1a,b)
(10 mmol) and benzaldehydes (2aei) (10 mmol) was stirred, and
then DABCO (3.36 g, 30 mmol) was added. The resulting mixture
was continually stirred and heated to the reflux for 20 h. Then, the
reaction mixture was extracted with CH2Cl2 (3ꢂ50 mL). The
resulting extracts were combined, washed with brine, dried over
anhydrous MgSO4 in sequence. After filtration, the filtrate was
concentrated in vacuo to give crude 4ae, which were further
purified by silica-gel column chromatography (EtOAc/n-
hexane¼1:5). Pure flavanones 4a (67%), 4b (71%), 4c (70%), 4d
AFC7S diffractometer with a graphite monochromator (
u
scans, 2qmax¼45.0o),
ꢀ
Mo K
a
radiation (
l
¼0.71073 A). The total number of independent reflections
measured was 1243, of which 774 were observed (jFj2S2
s
jFj2). The crystal
structure was solved by the direct method and expanded using difference
Fourier techniques, further refined by the program SHEXTL 97 and full-matrix
least-squares calculations. Final indices: Rf¼0.0701, Rw¼0.0819 (w¼1/
[s
2(Fo2)þ(0.1692P)2] where P¼(Fo2þ2Fc2)/3).
21. Mphahlele, M. J.; Fernandes, M. A. S. Afr. J. Chem. 2002, 55, 97e110.
22. Fujise, S.; Fujii, R.; Maeda, T.; Takagi, K.; Nakamura, S. Nippon Kagaku Zasshi
1953, 74, 827e829.
23. Aggarwal, V. K.; Emme, I.; Fulford, S. Y. J. Org. Chem. 2003, 68, 692e700.
24. Chimenti, F.; Fioravanti, R.; Bolasco, A.; Chimenti, P.; Secci, D.; Rossi, F.; Yanez,
M.; Orallo, F.; Ortuso, F.; Alcaro, S.; Cirilli, R.; Ferretti, R.; Sanna, M. L. Bioorg.
Med. Chem. 2010, 18, 1273e1279.
25. Joglekar, S. J.; Samant, S. D. Tetrahedron Lett. 1988, 2, 241e244.